For the Inventor, By the Inventor

Enter assignee name

Pittsford, NY, United States of America

Srx Cardio, LLC

USPTO Granted Patents = 13

EPO Patents = 1

Forward Citations = 37

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Thomas E Barta (13 out of 47 patents)

Jonathan William Bourne (13 out of 16 patents)

Kyle D Monroe (11 out of 13 patents)

4. Michael Mark Muehlemann (11 out of 29 patents)

5. Anjali Pandey (8 out of 81 patents)

6. Simeon Bowers (8 out of 25 patents)

7. Jiang Zhu (1 out of 6 patents)

8. Eric T Baldwin (1 out of 3 patents)

9. Mark Karbarz (1 out of 4 patents)

10. Margaret Thompson Reece (1 out of 1 patent)

11. Vesa Nevalainen (1 out of 4 patents)

13 patents: Sort by Forward Citations

1. 12115154 - Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) (2024-10-15),

2. 11945782 - Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity (2024-04-02),

3. 11944619 - Phenylalanine small organic compounds to directly modulate PCSK9 protein activity (2024-04-02),

4. 11925637 - Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use (2024-03-12),

5. 11891369 - Compounds for binding proprotein convertase subtilisin/kexin type 9 (2024-02-06),

6. 11771710 - Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands (2023-10-03),

7. 11026957 - Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands (2021-06-08),

8. 10980801 - Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use (2021-04-20),

9. 10865185 - Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity (2020-12-15),

10. 10568882 - Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use (2020-02-25),

11. 10307433 - Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity (2019-06-04),

12. 10287317 - Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels (2019-05-14),

13. 10034892 - Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity (2018-07-31),

SRX Cardio, LLC is a leading provider of innovative cardiovascular devices and solutions. We specialize in developing cutting-edge technologies to improve patient outcomes and streamline clinical practices. Our team of experts is dedicated to delivering high-quality products and exceptional customer service to healthcare professionals worldwide. Visit our website to learn more about our advanced cardiac solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#4 in Pittsford, NY

#1,281 in New York

#23,149 in US

#43,681 in the World

Pittsford, NY, United States of America

Srx Cardio, LLC

Forward Citations = 37

11 inventors:

Thomas E Barta (13 out of 47 patents)

Jonathan William Bourne (13 out of 16 patents)

Kyle D Monroe (11 out of 13 patents)

4. Michael Mark Muehlemann (11 out of 29 patents)

5. Anjali Pandey (8 out of 81 patents)

Please report any incorrect information to support@idiyas.com

Loading…